<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Using 1998-2005 SEER-Medicare data, we examined the effect of diagnostic and treatment delays on <z:hpo ids='HP_0000001'>all</z:hpo>-cause and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>)-specific <z:hpo ids='HP_0011420'>death</z:hpo> among US adults aged ≥ 66 years with invasive colon or <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that longer delays would be associated with a greater risk of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We defined diagnostic and treatment delays, respectively, as days between (1) initial medical consult for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> symptoms and pathologically confirmed diagnosis (maximum: 365 days) and (2) pathologically confirmed diagnosis and treatment (maximum: 120 days) </plain></SENT>
<SENT sid="3" pm="."><plain>Cases (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:hpo ids='HP_0011420'>deaths</z:hpo>) and controls (<z:hpo ids='HP_0011420'>deaths</z:hpo> due to other causes or censored) were matched on survival time </plain></SENT>
<SENT sid="4" pm="."><plain>Logistic regression analyses adjusted for sociodemographic, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>, and treatment factors </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Median diagnostic delays were 60 (colon) and 40 (rectal) days and treatment delays were 13 (colon) and 16 (rectal) days in 10,663 patients </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0003003'>Colon cancer</z:hpo> patients with the longest diagnostic delays (8-12 months vs. 14-59 days) had higher odds of <z:hpo ids='HP_0000001'>all</z:hpo>-cause (aOR: 1.31 CI: 1.08-1.58), but not <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-specific <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0003003'>Colon cancer</z:hpo> patients with the shortest treatment delays (&lt;1 vs. 1-2 weeks) had higher odds of <z:hpo ids='HP_0000001'>all</z:hpo>-cause (aOR: 1.23 CI: 1.01-1.49), but not <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-specific <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Among <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> patients, delays were not associated with risk of <z:hpo ids='HP_0000001'>all</z:hpo>-cause or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-specific <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Longer delays of up to 1 year after symptom <z:hpo ids='HP_0003674'>onset</z:hpo> and 120 days for treatment did not increase odds of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-specific <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>There may be little clinical benefit in detecting and treating existing symptomatic disease earlier </plain></SENT>
<SENT sid="11" pm="."><plain>Screening prior to symptom <z:hpo ids='HP_0003674'>onset</z:hpo> must remain the primary goal to reduce <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> incidence, morbidity, and mortality </plain></SENT>
</text></document>